BioCorRx (BICX) Cash from Financing Activities (2010 - 2026)
BioCorRx (BICX) posted Cash from Financing Activities of $505522.0 for Q1 2026, down 27.72% sequentially from $699394.0 in Q4 2025, and down 19.21% YoY from $625732.0 in Q1 2025.
BioCorRx (BICX) Cash from Financing Activities (2010 - 2026) Analysis & Trends
BioCorRx has reported Cash from Financing Activities for 17 years, with the latest figure at $505522.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 19.21% year-over-year to $505522.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 62.82% YoY) and the FY2025 annual result came in at $2.3 million, up 109.96% from the prior year.
- Cash from Financing Activities retreated to $505522.0 in Q1 2026 per BICX's latest filing, from $699394.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $1.0 million in Q1 2022 and troughed at $59158.0 in Q2 2024.
- A 5-year average of $461684.9 and a median of $442649.0 in 2023 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities slumped 89.53% in 2024, then surged 262.13% in 2025.
- Over 5 years, Cash from Financing Activities stood at $454662.0 in 2022, then slipped by 2.64% to $442649.0 in 2023, then fell by 24.29% to $335113.0 in 2024, then jumped by 108.7% to $699394.0 in 2025, then declined by 27.72% to $505522.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $505522.0, $699394.0, and $810263.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | -704.00 Mn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | -1.18 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | -76.90 Mn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | -270.19 Mn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | -41.45 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | -189.49 Mn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | -76.57 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | -33.21 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | -24.67 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 505,522.00 |
| Mar 31, 2026 | 505,522.00 |
| Dec 31, 2025 | 699,394.00 |
| Dec 31, 2025 | 699,394.00 |
| Sep 30, 2025 | 810,263.00 |
| Sep 30, 2025 | 810,263.00 |
| Jun 30, 2025 | 214,229.00 |
| Jun 30, 2025 | 214,229.00 |
| Mar 31, 2025 | 625,732.00 |
| Mar 31, 2025 | 625,732.00 |
| Dec 31, 2024 | 335,113.00 |
| Dec 31, 2024 | 335,113.00 |
| Sep 30, 2024 | 349,268.00 |
| Sep 30, 2024 | 349,268.00 |
| Jun 30, 2024 | 59,158.00 |
| Jun 30, 2024 | 59,158.00 |
| Mar 31, 2024 | 375,526.00 |
| Mar 31, 2024 | 375,526.00 |
| Dec 31, 2023 | 442,649.00 |
| Dec 31, 2023 | 442,649.00 |